HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:
Guest Access | Sign In via User Name/Password

This Article Full Text Free Full Text (PDF) Free Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Article Archive Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (8) Citing Articles via Google Scholar Google Scholar Articles by Imfeld, S. Articles by Russi, E. W. Search for Related Content PubMed PubMed Citation Articles by Imfeld, S. Articles by Russi, E. W.

The BODE Index After Lung Volume Reduction Surgery Correlates With Survival^*

^* From the Pulmonary Division (Drs. Imfeld, Bloch, and Russi) and Division of Thoracic Surgery (Dr. Weder), University Hospital, Zurich, Switzerland.

Correspondence to: Erich W. Russi, MD, FCCP, Pulmonary Division, University Hospital, Raemistr. 100, CH-8091 Zürich, Switzerland; e-mail: erich.russi{at}usz.ch

Abstract

Study objective: A recently introduced, multidimensional index called BODE (body mass index [BMI], degree of airflow obstruction assessed by spirometry, grade of dyspnea, and exercise capacity), quantified by 6-min walking distance (6MWD), has excellent predictive power with respect to outcome in COPD. We investigated whether the BODE index is able to predict survival after lung volume reduction surgery (LVRS).

Design: Retrospective study.

Setting: Tertiary university hospital.

Patients: One hundred eight-six COPD patients (76 women) with severe emphysema (mean ± SD age, 64 ± 8 years; mean FEV₁, 28 ± 8% of predicted).

Intervention: Bilateral thoracoscopic LVRS.

Measurements and results: BMI, pulmonary function, 6MWD, and the modified Medical Research Council dyspnea score were assessed before and 3 months after LVRS, and the BODE index was calculated. The patients were followed up with respect to survival for a median time of 40 months (range, 3 to 116 months) after surgery. The mean BODE index decreased from 7.2 ± 1.6 preoperatively to 4.0 ± 2.0 at 3 months after LVRS (p < 0.001). The postoperative but not the preoperative BODE correlated with survival, although preoperative patient characteristics were comparable between short-term (< 5 years) and long-term (> 5 years) survivors. A decrease to a lower BODE score class was associated with a reduced mortality (hazard ratio, 0.497, 95% confidence interval, 0.375 to 0.659; p < 0.001). The C statistic for the ability of the BODE index to predict the risk of death was larger (0.74) than that for the FEV₁ (0.63), the degree of dyspnea (0.64), or the 6MWD (0.62).

Conclusions: The postoperative BODE index is a powerful predictor of survival in COPD patients after LVRS.

Key Words: BODE index • COPD • lung volume reduction surgery • survival

This article has been cited by other articles:

				B. R. Celli Change in the BODE index reflects disease modification in COPD: lessons from lung volume reduction surgery. Chest, April 1, 2006; 129(4): 835 - 836. [Full Text] [PDF]